作者：Nabi Biopharmaceuticals(NABI)
| 发布于: | 公告 | 转发：0 | 回复：0 | 喜欢：0 |
$Nabi Biopharmaceuticals(NABI)$ DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material Filed: 2018-02-09 AccNo: 0000921895-18-000480 Size: 38 KB 网页链接